Dr. Aubrey de Grey of SENS Research Foundation was interviewed by the extremely popular Joe Rogan, and they discussed the damage repair approach to aging. Dr. de Grey talked about the current state of aging research, including stem cell therapies, and explained the role of SENS in developing next-generation rejuvenation biotechnology therapies. He also brought up the role of funding, a key bottleneck in research and development, and gave his prognosis on how quickly these therapies will be developed.
As always, if you would like to support work of this nature please follow SENS, LEAF, and get involved if you can – every person can make a difference, and every second counts when it comes to stopping age-related disease.
HELP SPREAD THE WORD
Please connect with us on social media, like and share our content, and help us build grass-roots support for healthy life extension:
On this episode of Science to Save the World, we discuss the relationship of cryptocurrencies and longevity, focusing on VitaDAO and related innovations. Script In our last episode, we dove into the […]
A study published in Cell Reports has found α-synuclein, the fundamental protein of Parkinson’s disease, to be critical in immune function. The gut-brain axis as a channel for disease Parkinson’s disease, which causes damage to the portion of the […]
93% of the world’s money is now digital, held in virtual ledgers across banks and other financial institutions. With the increasing digitalization of financial services, there is no doubt that we are heading […]
An outcomes study conducted by the Diabetes Prevention Program (DPP) has examined the effects of lifestyle interventions and the popular diabetes drug metformin on all-cause mortality. Background The original DPP […]
A recent study published in Biogerontology has discovered a potential new aging biomarker and longevity therapeutic target [1]. Isthmin 1 (Ism1) in aging fish Ism1 is not a well-known protein, but it has been shown to play a […]
Scientists have created genetically engineered T cells that target activated cardiac fibroblasts in a transient manner, alleviating symptoms of cardiac injury [1]. […]
Write a comment: